Ani Pharmaceuticals (ANIP) Times Interest Earned (2011 - 2026)

Ani Pharmaceuticals (ANIP) has 16 years of Times Interest Earned data on file, last reported at $1.01 in Q1 2026.

• For the quarter ending Q1 2026, Times Interest Earned rose 78.42% year-over-year to $1.01; the trailing twelve-month figure through Mar 2026 stood at $3.21 (up 2200.79% YoY), and the FY2025 full-year result was $2.3, up 20177.63% from the prior year.
• Times Interest Earned fell to $1.01 in Q1 2026, from $3.39 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $3.39 in Q4 2025 to a low of -$0.85 in Q4 2024.
• A 5-year average of $0.45 and a median of $0.43 in 2023 frame the typical range for Times Interest Earned.
• Across the five-year window, Times Interest Earned plunged 612.83% in 2022 and jumped 630.63% in 2023, its largest moves.
• Tracing ANIP's Times Interest Earned over 5 years: stood at $0.24 in 2022, then jumped by 125.5% to $0.55 in 2023, then slumped by 254.39% to -$0.85 in 2024, then soared by 499.0% to $3.39 in 2025, then plunged by 70.29% to $1.01 in 2026.
• Business Quant data shows ANIP's Times Interest Earned at $1.01 in Q1 2026, $3.39 in Q4 2025, and $0.75 in Q3 2025.